STAT5BN642H is a driver mutation for T cell neoplasia.

Saved in:
Bibliographic Details
Title: STAT5BN642H is a driver mutation for T cell neoplasia.
Authors: Pham HTT; Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria.; Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria., Maurer B; Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria.; Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria., Prchal-Murphy M; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria., Grausenburger R; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria., Grundschober E; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria., Javaheri T; Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria.; Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria., Nivarthi H; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Boersma A; Institute of Laboratory Animal Science, and., Kolbe T; Biomodels Austria (Biat), University of Veterinary Medicine Vienna, Vienna, Austria.; IFA-Tulln, University of Natural Resources and Life Sciences, Tulln, Austria., Elabd M; Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria., Halbritter F; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Pencik J; Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria., Kazemi Z; Medical University of Vienna, Vienna, Austria.; Center of Physiology and Pharmacology, Vienna, Austria., Grebien F; Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria., Hengstschläger M; Center of Pathobiochemistry and Genetics, Institute of Medical Genetics, Medical University of Vienna, Vienna, Austria., Kenner L; Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria.; Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.; Unit of Pathology of Laboratory Animals, University of Veterinary Medicine Vienna, Vienna, Austria., Kubicek S; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Farlik M; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Bock C; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.; Medical University of Vienna, Vienna, Austria.; Max Planck Institute for Informatics, Saarbrücken, Germany., Valent P; Department of Internal Medicine I, Division of Hematology and Hemostaseology, and.; Ludwig Boltzmann-Cluster Oncology, Medical University of Vienna, Vienna, Austria., Müller M; Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria., Rülicke T; Institute of Laboratory Animal Science, and., Sexl V; Institute of Pharmacology and Toxicology, University of Veterinary Medicine Vienna, Vienna, Austria., Moriggl R; Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria.; Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria.; Medical University of Vienna, Vienna, Austria.
Source: The Journal of clinical investigation [J Clin Invest] 2018 Jan 02; Vol. 128 (1), pp. 387-401. Date of Electronic Publication: 2017 Dec 04.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-8238
DOI:10.1172/JCI94509